doi: 10.1016/s1359-6446(99)01392-6.
Antisense oligonucleotides: a systematic high-throughput approach to target validation and gene function determination
Affiliations
- PMID: 10557138
- DOI: 10.1016/s1359-6446(99)01392-6
Item in Clipboard
Antisense oligonucleotides: a systematic high-throughput approach to target validation and gene function determination
Drug Discov Today.
1999 Dec.
Abstract
Antisense technology provides a high-throughput and systematic approach to drug target validation and gene function discovery. In combination with other emerging technologies (such as microarrays), this technology will enable efficient evaluation of the sequence data generated by the Human Genome Project. The authors review recent advances in the antisense field and discuss the potential use of antisense technology for functional genomics.
Similar articles
-
Antisense oligonucleotides for target validation and gene function determination.IDrugs. 1999 Aug;2(8):777-81. IDrugs. 1999. PMID: 16127653
-
Use of antisense oligonucleotides in functional genomics and target validation.Oligonucleotides. 2004 Spring;14(1):49-64. doi: 10.1089/154545704322988058. Oligonucleotides. 2004. PMID: 15104896 Review.
-
Tools for target identification and validation.Curr Opin Chem Biol. 2004 Aug;8(4):371-7. doi: 10.1016/j.cbpa.2004.06.001. Curr Opin Chem Biol. 2004. PMID: 15288246 Review.
-
Application of antisense oligonucleotides for gene functionalization and target validation.Curr Opin Mol Ther. 1999 Jun;1(3):359-71. Curr Opin Mol Ther. 1999. PMID: 11713801 Review.
-
Target validation and functional analyses using antisense oligonucleotides.Expert Opin Ther Targets. 2001 Jun;5(3):297-301. doi: 10.1517/14728222.5.3.297. Expert Opin Ther Targets. 2001. PMID: 12540266
Cited by
-
Rational design and rapid screening of antisense oligonucleotides for prokaryotic gene modulation.Nucleic Acids Res. 2006;34(19):5660-9. doi: 10.1093/nar/gkl715. Epub 2006 Oct 11. Nucleic Acids Res. 2006. PMID: 17038332 Free PMC article.
-
Antisense properties of tricyclo-DNA.Nucleic Acids Res. 2002 Jul 1;30(13):2751-7. doi: 10.1093/nar/gkf412. Nucleic Acids Res. 2002. PMID: 12087157 Free PMC article.
-
Nucleic acid aptamers for target validation and therapeutic applications.J Biomol Tech. 2005 Sep;16(3):224-34. J Biomol Tech. 2005. PMID: 16461946 Free PMC article.
-
Application of Artificial Intelligence in Discovery and Development of Anticancer and Antidiabetic Therapeutic Agents.Evid Based Complement Alternat Med. 2022 Apr 25;2022:6201067. doi: 10.1155/2022/6201067. eCollection 2022. Evid Based Complement Alternat Med. 2022. Retraction in: Evid Based Complement Alternat Med. 2023 Aug 9;2023:9782318. doi: 10.1155/2023/9782318. PMID: 35509623 Free PMC article. Retracted. Review.
-
Fundamental differences in the equilibrium considerations for siRNA and antisense oligodeoxynucleotide design.Nucleic Acids Res. 2008 Jun;36(11):3738-45. doi: 10.1093/nar/gkn266. Epub 2008 May 15. Nucleic Acids Res. 2008. PMID: 18483081 Free PMC article.
LinkOut - more resources
Full Text Sources
Other Literature Sources
